Biotech News

Charles River, Labcorp, and FDA Collaborate to Validate New Preclinical Methods for Abuse Potential Assessment

Charles River (CRL)Charles RiverFDA / regulatory

Joint research effort seeks to improve abuse potential assessment tools to support drug development and public health decision-making WILMINGTON, Mass. --(BUSINESS WIRE)--Oct. 22, 2026-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced a Research Collaboration Agreement

Related news

Charles River

Preclinical Research Services Charles River Laboratories provides products and outsourced services used by pharmaceutical, biotechnology, academic and government researchers across early drug development. Research Models and Services The company supplies research models and related services used in basic research, target validation and...

Recent company news

Stock data

Close
327.93 USD
Market cap
8.42B USD
Exchange
NYSE
Sector
Biopharma
Location
United States